Evolent Announces First Quarter 2026 Results WASHINGTON (

Evolent Announces First Quarter 2026 Results

Evolent Health, Inc. reported its financial results for Q1 2026, showing a revenue increase to $496.2 million from $483.6 million in Q1 2025. The company experienced a net loss of $26.6 million, significantly reduced from $72.3 million a year prior. Evolent is focused on expanding its oncology market presence and leveraging AI opportunities while maintaining commitments to stakeholders. The company anticipates a revenue range of $2.4 billion to $2.6 billion for the full year.

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results WASHINGTON (

Evolent Announces Third Quarter 2025 Results Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026. Expands leadership team to support

Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners Evolent reiterates outlook for Q3 2025 and full year 2025 for Revenue and Adjusted EBITDA, excluding the effect of t

Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock WASHINGTON

Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock WASHINGTON

Evolent Announces Second Quarter 2025 Results WASHINGTON (

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA Notes accelerating 2026 revenue bookings forecast Secures incremental non-dilutive financing WASHINGTON

Evolent Announces First Quarter 2025 Results WASHINGTON (

Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors Former CFO of CVS Health, Aetna and Coventry Health Care brings deep experience driving growth and profitability. Mr. Guertin'

Evolent Announces Fourth Quarter and Full Year 2024 Results Revenue of $646.5 million for the three months ended

Evolent Health Announces Changes to Board of Directors Richard "Rick" Jelinek to Be Named Chair of the Board at 2025 Annual Meeting Company Continues Board Refreshment Efforts with Brendan Springstubb's Appointment as Ne

Evolent Announces Third Quarter 2024 Results Revenue of $621.4 million, an increase of $110.4 million or 21.6% , from the three months ended

Evolent Announces Second Quarter 2024 Results Revenue of $647.1 million, an increase of $178.0 million or 37.9% , from the three months ended

Document Evolent signs agreement to acquire artificial intelligence utilization management products and team from Machinify Machinify solution seeks to accelerate the efficiency, quality, and clinical value of Evolent's

Evolent Announces First Quarter 2024 Results Revenue of $639.7 million, an increase of $212.0 million or 49.6%, from the three months ended

Evolent Health, Inc. Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited, in thousands, except per share data) For the Three Months Ended December 31, For the Year Ended

Document Evolent Adds Russell Glass, Headspace CEO, to Board of Directors WASHINGTON

Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan WASHINGTON

Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan WASHINGTON

COMBINED FINANCIAL STATEMENTS MAGELLAN SPECIALTY HEALTH (A Business of Magellan Health, Inc.)

Evolent Announces Third Quarter 2023 Results WASHINGTON (

Evolent Announces Second Quarter 2023 Results WASHINGTON (

1.95B 2023 Revenue Outlook at Midpoint 39%1 Revenue CAGR Q4 2019 - Q1 2023 $190M1 2023 Adjusted EBITDA Outlook at Midpoint ~110% Revenue Renewal Rate (2022) $50B Cross-Sell Revenue Opportunity out of $150B Specialty TAM

Evolent Health Announces First Quarter 2023 Results WASHINGTON (

Evolent Health Names New Independent Nominee for Election to Board of Directors Richard Jelinek nominated to join the Board current director David Farner to depart the Board in June 2023, in addition to previously announ

Evolent Health Announces Fourth Quarter and Full Year 2022 Results WASHINGTON (

Safe Harbor Statement Certain statements, including but not limited to estimates of Adjusted EBITDA, earnings growth, expected cost synergies and net leverage ratios, made in this presentation and in other written or ora

Safe Harbor Statement Certain statements made in this presentation and in other written or oral statements made by us or on our behalf are "forward-looking statements" within the meaning of the Private Securities Litigat

Evolent Health Announces Third Quarter 2022 Results WASHINGTON (

Evolent Health Announces Second Quarter 2022 Results Announces Four Operating Partner Additions WASHINGTON (

EVOLENT HEALTH TO ACQUIRE IPG - Expected to Accelerate Evolent Health's Position as a Leading Provider of Value-Based Specialty Care Solutions - Expands Evolent's Value-Based Specialty Care Solutions Portfolio to Musculo

Evolent Health Announces First Quarter 2022 Results Announces Two Operating Partner Additions and One Expansion WASHINGTON (

Evolent Health Announces Fourth Quarter and Full Year 2021 Results Announces Four New Partner Additions Washington, D.C., (

Evolent Health Announces Third Quarter 2021 Results Washington, D.C., (

Evolent Health Announces Agreement to Acquire Vital Decisions, Expanding its Depth and Breadth in Specialty Care Management The addition of Vital Decisions' specialized patient engagement services expected to position Ne

Evolent Health Announces First Quarter 2021 Results Washington, D.C., (

Evolent Health Announces Fourth Quarter and Full Year 2020 Results Washington, D.C., (

Evolent Health Enters Agreement with Bright HealthCare for Bright HealthCare to Acquire True Health New Mexico WASHINGTON

Evolent Health Announces Cooperation Agreement With Engaged Capital Appoints New Independent Director Craig Barbarosh to the Board Board to Form a Strategy Committee Focused on Value Creation Initiatives Company to Seek

Evolent Health Announces Third Quarter 2020 Results Washington, D.C., (

Evolent Health Announces Second Quarter 2020 Results WASHINGTON, D.C.

Evolent Health Announces First Quarter 2020 Results WASHINGTON, D.C.

Evolent Health Announces Fourth Quarter and Full Year 2019 Results WASHINGTON, D.C.

Evolent Health Announces Third Quarter 2019 Results WASHINGTON, D.C.

Evolent Health Announces Second Quarter 2019 Results WASHINGTON, D.C.

Evolent Health Expands Partnership with Passport Health Plan to Support Medicaid Beneficiaries in the Commonwealth of Kentucky Passport's owners select Evolent as Passport's long-term financial and operating partner for

Evolent Health Announces First Quarter 2019 Results WASHINGTON, D.C.

Exhibit Evolent Health, GlobalHealth and Kinderhook Industries Launch "True Health" to Support Provider-Led Medicare Advantage Plans Newly established joint venture True Health partners with leading providers to offer Me

Exhibit Evolent Health Announces Fourth Quarter and Full Year 2018 Results WASHINGTON, D.C.

Evolent Health Announces Third Quarter 2018 Results WASHINGTON, D.C.

Evolent Health, Inc. Announces Exercise of Option to Purchase Additional Convertible Senior Notes Due 2025 WASHINGTON

Exhibit Evolent Health, Inc. Announces Pricing of $150.0 Million of Convertible Senior Notes Due 2025 WASHINGTON

Exhibit Evolent Health, Inc. Announces Proposed Offering of $125.0 Million of Convertible Senior Notes Due 2025 WASHINGTON

Evolent Health Completes Acquisition of New Century Health WASHINGTON, D.C.

Evolent Health to Acquire New Century Health, Expanding its Specialty Care Management Capabilities The addition of New Century Health provides significant depth in managing high-cost specialty care for providers and paye

Evolent Health Announces Second Quarter 2018 Results WASHINGTON, D.C.

Exhibit Evolent Health Announces First Quarter 2018 Results WASHINGTON, D.C.

Exhibit Evolent Health Announces Fourth Quarter and Full Year 2017 Results WASHINGTON, D.C.

Evolent Health Overview January 2018 Safe Harbor Statement Certain statements in this presentation and in other written or oral statements made by us or on our behalf are "forward-looking statements" within the meaning o

Exhibit Evolent Health Completes Acquisition of Assets from New Mexico Health Connections WASHINGTON, D.C.

Exhibit Evolent Health and Premier Health Announce Termination of Agreement for Acquisition of Premier Health Plan WASHINGTON, D.C.

Exhibit Evolent Health Announces Third Quarter 2017 Results WASHINGTON, D.C.

Evolent Health Announces Proposed Expansion of Relationships in Illinois and New Mexico WASHINGTON, D.C.

Exhibit Evolent Health Announces Second Quarter 2017 Results WASHINGTON, D.C.

Exhibit Evolent Health Announces First Quarter 2017 Results WASHINGTON, D.C.

Exhibit Evolent Health Announces Fourth Quarter and Full Year 2016 Results WASHINGTON, D.C.

Exhibit Evolent Health, Inc. Announces Pricing of $110.0 Million of Convertible Senior Notes Due 2021 WASHINGTON

Exhibit Evolent Health, Inc. Announces Proposed Offering of $110 Million of Convertible Senior Notes Due 2021 WASHINGTON

Exhibit Evolent Health Announces Third Quarter 2016 Results Washington, DC, (

Exhibit Evolent Health Completes Acquisition of Valence Health The addition of Valence Health enhances Evolent's market-leading value-based care platform WASHINGTON, DC.

Exhibit Evolent Health Announces Second Quarter 2016 Results Washington, DC, (

Exhibit Evolent Health to Acquire Valence Health, Extending Breadth and Depth of Value-Based Care Offering The addition of Valence Health will enhance Evolent's market-leading value-based care platform for providers Wash

SEC Exhibit Evolent Health Announces First Quarter 2016 Results Washington, DC, (

Exhibit Evolent Health Announces Fourth Quarter and Full Year 2015 Results Washington, DC (

Exhibit Evolent Health Announces Third Quarter 2015 Results Washington, D.C., (

Exhibit Evolent Health Elects Cheryl Scott to Board of Directors Washington, D.C. (

Exhibit Evolent Health Elects Kenneth A. Samet to Board of Directors Washington, D.C. (

Evolent Health, Inc. 800 North Glebe Road, # 500 Arlington, Virginia 22203 Evolent Health Announces Second Quarter 2015 Results Arlington, VA

Evolent Health, Inc. Announces Closing of Initial Public Offering Washington, D.C. (

Evolent Health, Inc. Announces Pricing of Initial Public Offering Washington, D.C. (